Delivery Order SPE2DB22D2206-SPE2DB25FJD03
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed-price contract valued at $6,287.40. The delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a non-set-aside competitive award. The vaccine will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office operations. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,519.20 for Rabavert rabies vaccine with diluents on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price transaction for pharmaceutical supply to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed price contract. The award, valued at $1,047.90, was competitively awarded with no set-aside designation and carries an ultimate completion date of July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $26,596.25 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This firm fixed-price contract, effective July 25, 2025, with ultimate completion by July 28, 2025, represents a small-value pharmaceutical procurement from the prime contractor's place of business in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rabavert rabies vaccine with diluents under a firm fixed-price contract with a ceiling value of $1,467.06. The order, issued on July 31, 2025, is scheduled for ultimate completion by August 1, 2025, and represents a non-set-aside competitive award. AmerisourceBergen will perform this delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,047.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of September 12, 2025. This non-set-aside competitive award represents a single delivery order fulfillment under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $20,958.00 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This firm fixed price contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The award was not designated as a set-aside contract and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,816.02 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $13,409.25 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This firm fixed-price delivery order, issued on July 21, 2025, represents a competitively awarded contract with no set-aside designation and an ultimate completion date of July 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,297.80 firm fixed price delivery order for Rabavert rabies vaccine with diluents, effective August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJD03Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed-price contract valued at $18,728.13. The order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. This prime contract enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, specialty medications, and other critical medical commodities. The company's extensive federal procurement portfolio demonstrates its capability to meet Defense Department medical supply requirements through open competition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.7k | 7/29/25 |